These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19684634)

  • 1. Posterior reversible encephalopathy syndrome as a consequence of high dose steroid administration after autologous PBSCT.
    Sukumaran S; George B; Nair HP; Drobyski WR
    Bone Marrow Transplant; 2010 Apr; 45(4):779-80. PubMed ID: 19684634
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemophagocytic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma; successful treatment with high-dose intravenous immunoglobulin.
    Ostronoff M; Ostronoff F; Coutinho M; Calixto R; Souto Maior AP; Sucupira A; Florencio R; Tagliari C
    Bone Marrow Transplant; 2006 Apr; 37(8):797-8. PubMed ID: 16518425
    [No Abstract]   [Full Text] [Related]  

  • 3. Strongyloidiasis pre and post autologous peripheral blood stem cell transplantation.
    Orlent H; Crawley C; Cwynarski K; Dina R; Apperley J
    Bone Marrow Transplant; 2003 Jul; 32(1):115-7. PubMed ID: 12815488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients.
    Carreras E; Rosiñol L; Terol MJ; Alegre A; de Arriba F; García-Laraña J; Bello JL; García R; León A; Martínez R; Peñarrubia MJ; Poderós C; Ribas P; Ribera JM; San Miguel J; Bladé J; Lahuerta JJ;
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1448-54. PubMed ID: 18022574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perforation of the superior vena cava after subclavian catheterization: a rare complication after autologous PBSCT.
    Abdelkefi A; Ben Gaied O; Ladeb S; Labbène I; Torjman L; Lakhal A; Ferjani M; Ben Othman T
    Bone Marrow Transplant; 2009 Jun; 43(11):891-2. PubMed ID: 19104494
    [No Abstract]   [Full Text] [Related]  

  • 6. A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma.
    Einsele H; Bamberg M; Budach W; Schmidberger H; Hess CF; Wörmann B; Meisner C; Straka C; Hebart H; Trümper L; Kröger N; Zander AR; Hegewisch-Becker S; Hossfeld DK; Schmidt H; Müller P; Schlimok G; Hertenstein B; Peest D; Metzner B; Frickhofen N; Kanz L; Bensinger WI
    Bone Marrow Transplant; 2003 Sep; 32(6):593-9. PubMed ID: 12953132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder presenting with skin involvement after CD34-selected autologous peripheral blood stem cell transplantation.
    Takahashi S; Watanabe D; Miura K; Ozawa H; Tamada Y; Hara K; Matsumoto Y
    Eur J Dermatol; 2007; 17(3):242-4. PubMed ID: 17478388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic microangiopathy after combined autografting-allografting for multiple myeloma - report of three cases.
    Kornacker M; Luft T; Ho AD; Schaefer HJ
    Eur J Haematol; 2005 Mar; 74(3):250-3. PubMed ID: 15693795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus leukoencephalopathy--is it posterior reversible encephalopathy syndrome?
    Zhang HL
    Pediatr Neurol; 2011 Mar; 44(3):236; author reply 236. PubMed ID: 21310344
    [No Abstract]   [Full Text] [Related]  

  • 10. Continuing erythropoietin during peripheral blood stem cell collection in myeloma: can it reduce toxicity of autologous transplants?
    Labonté L; Iqbal T; McDiarmid S; Bence-Bruckler I; Huebsch L; Allan D
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):132-3. PubMed ID: 18158970
    [No Abstract]   [Full Text] [Related]  

  • 11. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation for the treatment of multiple myeloma refractory to conventional chemotherapy].
    Shimokawa T; Kajiguchi T; Saito M; Kojima Y; Takeyama H
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):251-4. PubMed ID: 12610874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma.
    Thieblemont C; Dumontet C; Saad H; Roch N; Bouafia F; Arnaud P; Hequet O; Espinouse D; Salles G; Roy P; Eljaafari-Corbin A; Du Manoir-Baumgarten C; Coiffier B
    Bone Marrow Transplant; 2002 Dec; 30(11):769-75. PubMed ID: 12439700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma.
    Harousseau JL; Attal M; Divine M; Milpied N; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M
    Bone Marrow Transplant; 1995 Jun; 15(6):963-9. PubMed ID: 7581098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evans' syndrome following autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Kamezaki K; Fukuda T; Makino S; Harada M
    Clin Lab Haematol; 2004 Aug; 26(4):291-3. PubMed ID: 15279667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma.
    Arango JI; Restrepo A; Schneider DL; Callander NS; Ochoa-Bayona JL; Restrepo MI; Bradshaw P; Patterson J; Freytes CO
    Bone Marrow Transplant; 2006 Mar; 37(5):517-21. PubMed ID: 16435018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelodysplastic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma.
    Przepiorka D; Buadi F; McClune B; Franz G; Walsh W; White F
    Bone Marrow Transplant; 2007 Oct; 40(8):759-64. PubMed ID: 17680015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversibility of cytotoxic edema in tacrolimus leukoencephalopathy.
    Yilmaz S; Gokben S; Arikan C; Calli C; Serdaroglu G
    Pediatr Neurol; 2010 Nov; 43(5):359-62. PubMed ID: 20933182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in multiple myeloma survivors treated with high dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation: a retrospective analysis.
    Slovacek L; Slovackova B; Pavlik V; Hrstka Z; Macingova Z; Jebavy L; Horacek JM
    Neoplasma; 2008; 55(4):350-5. PubMed ID: 18505348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantation.
    Egerer G; Goldschmidt H; Hensel M; Harter C; Schneeweiss A; Ehrhard I; Bastert G; Ho AD
    Bone Marrow Transplant; 2002 Oct; 30(7):427-31. PubMed ID: 12368954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous peripheral blood stem cell transplantation in multiple myeloma using oral versus I.V. melphalan.
    Vela-Ojeda J; García-Ruiz-Esparza MA; Padilla-González Y; Gómez-Almaguer D; Gutiérrez-Aguirre CH; Gómez-Rangel D; Morales-Toquero A; Ruiz-Delgado GJ; Delgado-Lamas JL; Ruiz-Argüelles GJ
    Ann Hematol; 2007 Apr; 86(4):277-82. PubMed ID: 17262193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.